Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 20;14(5):e0217038.
doi: 10.1371/journal.pone.0217038. eCollection 2019.

Carvedilol inhibits EGF-mediated JB6 P+ colony formation through a mechanism independent of adrenoceptors

Affiliations

Carvedilol inhibits EGF-mediated JB6 P+ colony formation through a mechanism independent of adrenoceptors

Kristan H Cleveland et al. PLoS One. .

Abstract

Carvedilol is reported to prevent cancers in humans and animal models. However, a molecular mechanism has yet to be established, and the extent to which other β-blockers are chemopreventive remains relatively unknown. A comparative pharmacological approach was utilized with the expectation that a mechanism of action could be devised. JB6 Cl 41-5a (JB6 P+) murine epidermal cells were used to elucidate the chemopreventative properties of β-blockers, as JB6 P+ cells recapitulate in vivo tumor promotion and chemoprevention. The initial hypothesis was that β-blockers that are GRK/β-arrestin biased agonists, like carvedilol, are chemopreventive. Sixteen β-blockers of different classes, isoproterenol, and HEAT HCl were individually co-administered with epidermal growth factor (EGF) to JB6 P+ cells to examine the chemopreventative properties of each ligand. Cytotoxicity was examined to ensure that the anti-transformation effects of each ligand were not due to cellular growth inhibition. Many of the examined β-blockers suppressed EGF-induced JB6 P+ cell transformation in a non-cytotoxic and concentration-dependent manner. However, the IC50 values are high for the most potent inhibitors (243, 326, and 431 nM for carvedilol, labetalol, and alprenolol, respectively) and there is no correlation between pharmacological properties and inhibition of transformation. Therefore, the role of α1- and β2-adrenergic receptors (AR) was examined by standard competition assays and shRNA targeting β2-ARs, the only β-AR expressed in JB6 P+ cells. The results reveal that pharmacological inhibition of α1- and β2-ARs and genetic knockdown of β2-ARs did not abrogate carvedilol-mediated inhibition of EGF-induced JB6 P+ cell transformation. Furthermore, topical administration of carvedilol protected mice from UV-induced skin damage, while genetic ablation of β2-ARs increased carvedilol-mediated effects. Therefore, the prevailing hypothesis that the chemopreventive property of carvedilol is mediated through β-ARs is not supported by this data.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Carvedilol prevented EGF-mediated transformation of JB6 P+ cells independently of its cytotoxic effects.
Examination of carvedilol in three assays: 10 μM EGF-mediated JB6 P+ cell colony formation in soft agar (black) n = 20 to 22, 72-hour SRB cell viability assay (blue) n = 6, and 2-week MTS cell viability assay (pink) n = 6. There is no statistical difference between SRB and MTS assays. Data represented as mean ± SD after normalization to control (EGF minus DMSO control for soft agar, and DMSO for SRB and MTS).
Fig 2
Fig 2. Select β-AR ligands prevent EGF-mediated neoplastic transformation of JB6 P+ cells.
Exposure of JB6 P+ cells to 10 ng/mL EGF and the indicated concentration of β-AR ligands for 2-weeks in soft agar (black); n = 5 to 25. For cell viability experiments, JB6 P+ cells were exposed to the indicated concentration of β-AR ligands for 72 hrs for an SRB assay (blue); n = 6. Data represented as mean ± SD after normalization to control (EGF minus DMSO control for soft agar, and DMSO for SRB).
Fig 3
Fig 3. β-blocker-mediated inhibition of EGF-induced neoplastic transformation of JB6 P+ cells does not correlate with β2-AR affinity or lipophilicity.
The x-axis is the reported logKd values (A and B), and XLogP3 obtained from PubChem (C). The y-axis is (A) logIC50 and (B and C) logIΔ2*PSD values for transformation. Pearson’s correlation shows that there is no correlation between log Kd values and either measurement, but there is a correlation between XLogP3 and logIΔ2*PSD. The dotted gray line represents the 95% confidence interval of the linear regression (gray line). For clarity, labels only appear in panel A. In panel B green and black symbols represent effective and non-effective β-blockers as shown in Table 1, respectively, and an orange circle represents β-blockers that are reported to have biased characteristics at the β2-AR. Panel C is similarly color-coded with open circles representing ineffective β-blockers, green circles represent effective β-blockers, and the orange halo represents β-blockers that are reported to have biased characteristics at the β2-AR.
Fig 4
Fig 4. Expression of α1-ARs and role of α1-ARs in EGF-induced neoplastic transformation of JB6 P+ cells.
(A) Universal mouse (positive control) and JB6 P+ cDNA was amplified with primers specific for each α1- and β-AR. Only α1D-AR and β2-AR are expressed in JB6 P+ cells. (B) 10 ng/mL EGF-mediated JB6 P+ cell colony formation in soft agar (black) n = 8 and 72-hour SRB cell viability assay (blue) n = 6. Data represented as mean ± SD after normalization to control (EGF minus DMSO control for soft agar, and DMSO for SRB and MTS). A red asterisk (*) indicate that the HEAT HCl data are statistically lower than control (p < 0.05 as per an ANOVA with Tukey-Kramer post hoc test), which is not shown for the colony formation assay, indicating toxicity.
Fig 5
Fig 5. Antagonism of adrenergic receptors fails to prevent carvedilol-mediated inhibition of EGF-induced neoplastic transformation of JB6 P+ cells.
JB6 P+ cells were exposed to EGF (10 ng/ml) and increasing concentrations of carvedilol (Car) in the absence and presence of (A) 10 μM nadolol, (B) 10 μM CGP 12177, or (C) 100 nM HEAT HCl. Cells were cultured for 14 days and the colonies counted under a microscope, n = 8. Data represented as mean ± SD after normalization to control (EGF alone minus DMSO control).
Fig 6
Fig 6. Knockdown of the β2-AR fails to prevent carvedilol-mediated inhibition of EGF-induced neoplastic transformation of JB6 P+ cells.
(A) qPCR indicates that transduction of JB6 P+ cells with lentiviruses carrying a short hairpin sequence for Adrb2 decreases β2-AR expression, n = 3. Statistical analyses were determined using a 2-Factor ANOVA followed by Tukey Kramer post hoc test; different Greek letters signify statistical differences (P < 0.05). Data represented as mean ± SD. (B) After 3-days of infection, the JB6 P+ cells were exposed to 10 ng/ml EGF for seven days and increasing concentrations of carvedilol; n = 3 independent experiments with eight internal replicates detailed in Table 2. Data represented as mean ± SD after normalization to control (EGF alone minus DMSO control).
Fig 7
Fig 7. Short term UV-induced epidermal thickening in wild-type and β2-adrenergic receptor knockout mice.
Hairless mice were exposed to 200 mJ/cm2 UV on day 1 and subsequently exposed to radiation every other day. On opposing days bi-fold epidermal thickness was measured with calipers, then the mice were treated with vehicle, 5 μM 4-OHC, or 5 μM carvedilol. Closed symbols represent wild type and open symbols knockout. Statistical analysis was conducted by a 3-Way RM-ANOVA and a Tukey-Kramer post hoc test. For clarity, statistical differences are noted in the text. Data represented as mean ± SD; n = 3, except for 4-OHC which had two mice in each group.

Similar articles

Cited by

References

    1. Curtis BM, O'Keefe JH Jr. Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clin Proc. 2002;77(1):45–54. Epub 2002/01/17. 10.4065/77.1.45 . - DOI - PubMed
    1. Eng JW, Kokolus KM, Reed CB, Hylander BL, Ma WW, Repasky EA. A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic response. Cancer Immunol Immunother. 2014;63(11):1115–28. 10.1007/s00262-014-1617-9 - DOI - PMC - PubMed
    1. Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010;70(18):7042–52. 10.1158/0008-5472.CAN-10-0522 - DOI - PMC - PubMed
    1. Sood AK, Bhatty R, Kamat AA, Landen CN, Han L, Thaker PH, et al. Stress hormone-mediated invasion of ovarian cancer cells. ClinCancer Res. 2006;12(2):369–75. - PMC - PubMed
    1. Cakir Y, Plummer HK III, Tithof PK, Schuller HM. Beta-adrenergic and arachidonic acid-mediated growth regulation of human breast cancer cell lines. IntJOncol. 2002;21(1):153–7. - PubMed

Publication types

MeSH terms